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Fragments derived from human plasma fibronectin by enzymatic degradation were tested in the Boyden 
chamber for chemotactic activity towards various fibroblast strains. The results provide clear evidence that 
the chemotactic activity is restricted to a defined region of the fibronectin molecule which is the same for 
various ~brobI~t strains. The active domain is localized between the collagen binding site and the major 
heparin binding site, about 170 kDa apart from the N-terminal and about ‘70 kDa from the C-terminal 
ends of the two subunit peptide chains. 
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1. INTRODUCTION 
Fibronectins (FN) are high-W, multifunctional 
glycoproteins, present in the extracellular matrix, 
in most basement membranes and, in a soluble 
form, in the blood plasma. They exhibit affinity to 
cell surfaces and bacterial cell walls, to heparin, 
fibrin, gelatin and actin. Fibronectin is capable of 
mediating cell attachment to collagen as well as cell 
spreading on matrix substances (reviews [l-3]). 
Another property of FN is the induction of 
fibroblast chemotaxis, a process which may play a 
role in wound healing [4]. Both plasma and cellular 
fibronectin are equally active in the induction of 
fibroblast chemotaxis [5]. 
chromatography and subsequently tested for their 
biological activities [l-3,19]. Here, we used this 
approach to identify the chemotactically active 
region towards fibroblasts by the use of the 
Boyden chamber assay. 
2. MATERIALS AND METHODS 
2.1. Cell culture technique 
Human plasma fibronectin is composed of two 
similar but not identical pol~eptides (A and B 
chains) with slightly different M,-values of 
-250000 [6-81. These subunits are linked via 
disulfide bridges close to their carboxy-terminal 
ends [9,10]. 
Human embryo fibroblasts were derived from a 
skin biopsy of a &week-old fetus after legal abor- 
tion and subcultivated in Dulbecco’s MEM sup- 
plemented with penicillin (400 U/ml), strep- 
tomycin (50 pg/ml), glutamine (300 fig/ml), ascor- 
bic acid (50pg/ml) and 10% fetal calf serum 
(FCS). For chemotaxis experiments cells were used 
in passages 8-12 and not later than 3 days after 
last trypsinisation. 
The FN polypeptide chains consist of highly 
structured domains separated by regions of flexible 
segments. Proteolytic digestion renders fragments 
of FN which can be isolated by affinity 
Cells derived from fibrosarcoma, HT-1080 
(strain ATCC-CCL 121) and from rhabdomyosar- 
coma RD (strain ATCC-CCL 136) were obtained 
from the American Type Culture Collection and 
grown in Dulbecco’s MEM supplemented as 
above. 
2.2. Chemotaxis 
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Corp., Pleasanton CA) were coated with gelatin 
(5 pg/ml; Sigma) as in [l 11. Cells were harvested 
by short trypsinisation (0.25% trypsin, 0.1% 
ethylenediamine tetraacetate), suspended in MEM 
containing 10% FCS to inactivate the enzyme, cen- 
trifuged and resuspended in MEM without FCS. 
Cells (1.5-2.5 x lO’/ml) were placed in the upper 
compartment of the Boyden chamber (0.8 ml). 
The lower compartment (0.2 ml) contained the 
peptide to be tested for chemoattractivity (protein 
was l-200 nM) in MEM without FCS. The 
chambers were incubated at 37°C in 5% COz, 95% 
air for 4 h. Non-migrated cells on the upper side of 
the filter were removed mechanically. Migrated 
cells on the lower side were fixed on the filter with 
ethanol and stained with toluidine blue. Migrated 
cells were counted at a 400-fold magnification with 
a Zeiss microscope (C. Zeiss, Oberkochen). Each 
sample was assayed in triplicate and cells in 5 unit 
fields were counted. 
2.3. Purification of fibronectin and its fragments 
Human plasma fibronectin purified as in [12] 
was used as chemoattractant and for the produc- 
tion of proteolytic fragments. A chymotryptic 
digest [12] was dialysed against 0.05 M Tris-HCl 
(pH 7.4), 1 mM EDTA and fractionated on 
heparin-Sepharose (column 2.5 x 17 cm) using 
stepwise elution with 0.05, 0.1 and 0.5 M NaCl. 
The chymotryptic peptide with 125 kDa 
(designated: Ch-125) was purified from the 0.05 M 
eluate fraction by removal of contaminating pep- 
tides on gelatin-Sepharose followed by molecular 
sieve chromatography. The gelatin non-binding 
Ch-160,180 material was present in the 0.5 M 
NaCl eluate and was purified as described for the 
Ch-125 peptide. 
The cathepsin D-derived fragment Ca-140 was 
prepared by mild digestion (enzyme: substrate = 
1: 300; 4 h) of human FN and purified as in [8]. 
Fragments Ca-95 and Ca-23 were prepared from a 
heparin non-binding fraction of a more processed 
digest (fraction I in [ 131) by chromatography on 
Ultrogel AcA44. Ca-18 was obtained from the 
gelatin binding chymotryptic fragment Ch-60 by 
further digestion with cathepsin D and purified on 
heparin-Sepharose [12]. Material of same p1 and 
similar amino acid composition was obtained from 
a cathepsin D digest (enzyme: substrate = 1: 30; 
24 h) of purified Ca-140 peptide (unpublished). 
Ca-15 is present in the above digest of Ca-140 as 
well as in a similar digest of Ch-125 from which it 
was isolated by chromatography on Ultrogel 
AcA54. 
The plasmic fragments Pl-85 (gelatin binding) 
and PI-90 (gelatin non-binding) resulted from a 
prolonged digest (Forschungsplasmin KABI, en- 
zyme : substrate = 1:20; 24 h; 37OC) of isolated 
Ca-200 peptide [8] and were isolated by successive 
chromatography on gelatin-Sepharose, heparin- 
Sepharose and Ultrogel AcA44 as will be described 
elsewhere. &Values of the peptides were deter- 
mined by SDS gel electrophoresis as in [14]; 
globular proteins of it4, reference kits from Bio- 
Rad and Pharmacia were used as standards. [Pro- 
tein] was estimated spectrophotometrically using 
A%, = 12.8 [6]. 
3. RESULTS AND DISCUSSION 
The chemotactic response to fibronectin and to 
proteolytic fragments of this glycoprotein was in- 
Table 1 
Number of migrated cells/unit field using FN peptides as 
chemoattractants in the Boyden chamber (protein was 
100 nM) 
Lower Upper compartment 
compartment 
HT 1080 RD HE-F Migrated 
cells (Ore) 
FN 
Ca-200 
Ca-70 
Ca-140 
Ca-75-SS-65 
Ca-18 
Ca-95 
Ca-23 
Ca-15 
PI-30 
Pl-85 
Pl-90 
Ch-160,180 
Ch-125 
Cathepsin D 
digest of 
Ch-125 
MEM control 
165 + 15 125 f 15 70 f 10 100070 
n.d. n.d. 70* 10 100% 
3 f 2 n.d. 2* 1 <5% 
170 f 10 130 f 12 75 * 10 100% 
8* 3 6* 2 4* 1 5070 
n.d. n.d. 2* 1 <5(rlo 
5* 2 4* 2 3* 1 <5010 
20* 4 15* 3 8* 2 12% 
7f 3 5* 2 4* 2 5% 
n.d. n.d. 3+ 1 <5% 
3 f 1 n.d. 3+ 2 <5010 
155 f 15 115 f 10 60 f 8 95% 
165 f 10120 f 15 65 f 10 1OOqo 
n.d. n.d. 68 f 12 100% 
8* 3 6k 2 3* 2 5070 
3* 2 3* 1 2* 1 <5% 
n.d. = not determined 
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Fig. 1. Chemotactic response of human fibrosarcoma 
(HT-1080), rhabdomyosarcoma (RD) and human 
embryo fibroblast (HE-F) cells to fibronectin (0), 
chymotryptic fragments Ch-160,180 (A) and cathepsin 
D-derived fragment Ca-140 (0). See section 2 for 
details. 
vestigated using 3 different cell strains: human em- 
bryo fibroblasts (HE-F), HT 1080 fibrosarcoma 
cells and RD rhabdomyosarcoma cells. The latter 
two cell types migrated in a fibronectin gradient 
with a rather high rate [5,15], in our hands 165 + 
15 and 125 + 15 cells/unit field, respectively, com- 
pared to 70 f 10 HE-F cells (table 1, fig.1). The 
NH2- 
Ca-200 
number of migrated cells increased up to 100 nM 
fibronectin (25 pug/ml) in the lower compartment 
of the Boyden chamber beyond which it remained 
on a plateau level [5]. 
The chemotactic region of fibronectin has been 
localized within a large cell binding chymotryptic 
160 kDa peptide [16] and in a gelatin non-binding 
cathepsin D-derived 140 kDa peptide [17]. To 
localize the chemotactic active site in the fibronec- 
tin subunit chains more exactly, additional 
purified fragments from proteolytic digests of 
fibronectin were tested as chemoattractants (table 
1). The position of many of those peptides within 
the fibronectin subunit chains was already known 
[f&18], while the correlation of others was so far 
tentative and was corroborated by these results 
(fig.2). 
Among the cathepsin D-derived peptides an ear- 
ly 140 kDa gelatin non-binding fragment (Ca-140) 
representing the central part of the peptide chains 
[8] showed full activity (fig.1). This fragment is 
most probably identical with the above 140 kDa 
peptide described in [17]. The gelatin binding N- 
terminal peptide Ca-70 was inactive (< 5%) and the 
double-chain C-terminal fragment Ca-75-SS-65 
(present in the heparin binding fraction IV [13]) 
was very poorly active (59’0). Full response was 
also obtained with the Ca-200 fragment [8] com- 
co-75-s-s- 65 -COOH 
1 ct’: 
gelat in Sinding A-chain 
4 
La-70 
NH2_ _ ,,: _ B-chain 5Iz 
+ 
Ch-28 Ch-60 Ch-125 
4 4 > -- w 
* e Ch-1 6OIfrom Al 
4 w Ch-18Q(fromBI 
PI-30 PI-85 pI-90 
Ca-18 Ca-95 
chemo I act ic 
domain 
Fig.2. Localization of the chemotactic domain within the fibronectin subunits based on data in table 1. Chemoattractive 
cathepsin D-derived (Ca), chymotryptic (Ch) and plasmic (Pl) fibronectin fragments are underlined. The white boxes 
indicate the position of the gelatin binding domain which was useful for affinity purification and localization of 
respective fragments. 
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prising the N-terminal 70 kDa and the central 
140 kDa region. From a more advanced digest 
peptides Ca-95, Ca-23, Ca-18 and Ca-15 represen- 
ting further cathepsin D cleavage products of the 
central Ca-140 piece (unpublished) were in- 
vestigated. Ca-23 showed little, but significant ac- 
tivity (12%). It is the precursor of the very poorly 
active (5%) fragment Ca-15 [18]. The other 
fragments were inactive. Ca-18 had been localized 
adjacent to the N-terminal Ca-70 peptide [ 121 and, 
therefore, should occupy the N-terminal part of 
Ca-140. 
Further information on the chemoattractive site 
came from peptides obtained by plasmic digestion 
of the above Ca-200 fragment ranging from the N- 
terminus of the fibronectin subunits to the end of 
the central region. Plasmin clipped off rapidly the 
N-terminal peptide PI-30 [9, lo] and subsequently 
generated mainly the two peptides Pl-85 and PI-90. 
Pl-85, lacking chemotactic activity, bound to 
gelatin-Sepharose. This indicates a position adja- 
cent to Pl-30 (fig.2). The gelatin non-binding 
PI-90, which is chemotactically active (95%), 
represents the C-terminal region of Ca-200. 
Some chymotryptic peptides were also tested. 
Large heparin binding fragments of 160 and 
180 kDa (designated: Ch-160,180) gave full 
chemotactic response (fig. 1). They lacked gelatin 
binding capacity and thus were located in a posi- 
tion adjacent to the gelatin binding center up to the 
highly protease-sensitive site very close to the C- 
terminal end of the shorter B-chain (Ch-180) or to 
a chymotrypsin cleavage site about 30 kDa apart 
from the C-terminus of the longer A-chain 
&h-160), respectively (fig.2). Therefore, the 
presence of these 2 related peptides reflects the 
slight difference in the C-terminal part of the 2 
fibronectin subunits. Another chemoattractive 
peptide was Ch-125 (100%) which, as it lacked 
gelatin and heparin binding capacity, was derived 
from the central region. Further cathepsin D diges- 
tion of the active Ch-125, giving rise to the poorly 
active Ca-15 isolated, destroys the chemotactic ac- 
tivity nearly completely (5%). This suggests that 
either a further cleavage of Ca-23 abolishes the 
chemotactically active center or the peptide might 
change its original conformation with loss of 
biological activity. 
These data give sufficient information to 
localize the chemoattractive site within the 
fibronectin subunits. It is comprised in the central 
region covered by peptide Ca-140. As peptides 
Ca-18 and Pl-85 containing sequences from the N- 
terminal half of Ca-140 failed to give a chemotac- 
tic response, the activity must be located within the 
C-terminal half of Ca-140 covered by peptide 
Pl-90. Another inactive peptide was Ca-95. 
Therefore, this peptide only can be correlated to a 
position adjacent o the C-terminus of Ca-18. Con- 
sequently, the chemoattractice site is localized in 
the utmost C-terminal position of Ca-140 of about 
30 kDa. The weakly active peptide Ca-23 has to be 
derived from this part. 
In 1191, the cell binding site of fibronectin was 
attributed to a tryptic 75 kDa fragment, the posi- 
tion of which was shown to be 72 kDa apart from 
the C-terminal end of the A-chain of 58 kDa from 
the B-chain C-terminus. According to our data the 
chemoattractive site should be in the C-terminal 
half of this fragment. 
Our results provide clear evidence that the 
chemotactic activity is restricted to a defined do- 
main of fibronectin which is the same towards 
various fibroblast strains. 
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